Articles dans des revues avec comité de lecture (220)
  1. 20. Calabrò, M., Fabbri, C., Kasper, S. S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., Colombo, R., De Ronchi, D., Serretti, A., & Crisafulli, C. (2021). Research domain criteria (Rdoc): A perspective to probe the biological background behind treatment efficacy in depression. Current medicinal chemistry, 28(22), 4296-4320. doi:10.2174/0929867328666210104104938
  2. 21. Bartova, L., Dold, M., Fugger, G., Kautzky, A., Mitschek, M. M. M., Weidenauer, A., Hienert, M. M., Frey, R., Mandelli, L., Zohar, J., Mendlewicz, J., Souery, D., Montgomery, S., Fabbri, C., Serretti, A., & Kasper, S. S. (2021). Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression. Depression and anxiety. doi:10.1002/da.23165
  3. 22. Fabbri, C., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., Serretti, A., & Lewis, C. C. (2021). Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression. Journal of affective disorders, 279, 722-729. doi:10.1016/j.jad.2020.10.049
  4. 23. Fabbri, C., Kasper, S. S., Kautzky, A., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., Uher, R., Lewis, C. C., & Serretti, A. (2020). A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping. Translational Psychiatry, 10(1), 50. doi:10.1038/s41398-020-0738-5
  5. 24. Fugger, G., Dold, M., Bartova, L., Mitschek, M. M. M., Souery, D., Mendlewicz, J., Serretti, A., Zohar, J., Montgomery, S., Fabbri, C., Frey, R., & Kasper, S. (2020). Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression. The international journal of neuropsychopharmacology, 23(9), 571-577. doi:10.1093/ijnp/pyaa035
  6. 25. Porcelli, S., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Ferentinos, P., Rujescu, D., Mendlewicz, J., Merlo Pich, E., Pollentier, S., Penninx, B. B., & Serretti, A. (2020). Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples. Progress in neuro-psychopharmacology & biological psychiatry, 99, 109835. doi:10.1016/j.pnpbp.2019.109835
  7. 26. Calabrò, M., Porcelli, S., Crisafulli, C., Albani, D., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Mantovani, V., Mendlewicz, J., Bonassi, S., Vieta, E., Frustaci, A., Ducci, G., Landi, S., Boccia, S., Bellomo, A., Di Nicola, M., Janiri, L., Colombo, R., Benedetti, F., Mandelli, L., Fabbri, C., & Serretti, A. (2020). Genetic variants associated with psychotic symptoms across psychiatric disorders. Neuroscience letters, 720, 134754. doi:10.1016/j.neulet.2020.134754
  8. 27. Fanelli, G., Benedetti, F., Kasper, S. S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., Serretti, A., & Fabbri, C. (2020). Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder. Progress in neuro-psychopharmacology & biological psychiatry., 110170. doi:10.1016/j.pnpbp.2020.110170
  9. 28. Dold, M., Bartova, L., Fugger, G., Mitschek, M. M. M., Kautzky, A., Frey, R., Montgomery, S., Zohar, J., Mendlewicz, J., Souery, D., Fabbri, C., Serretti, A., & Kasper, S. S. (2020). Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study. European neuropsychopharmacology. doi:10.1016/j.euroneuro.2020.09.636
  10. 29. Fugger, G., Dold, M., Bartova, L., Kautzky, A., Souery, D., Mendlewicz, J., Serretti, A., Zohar, J., Montgomery, S., Frey, R., & Kasper, S. S. (2019). Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression. Progress in neuro-psychopharmacology & biological psychiatry, 94, 109638. doi:10.1016/j.pnpbp.2019.109638
  11. 30. Köhler-Forsberg, O., Larsen, E. R., Buttenschøn, H. N., Rietschel, M., Hauser, J. W., Souery, D., Maier, W., Farmer, A., McGuffin, P., Aitchison, K., Uher, R., & Mors, O. (2019). Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder. British journal of psychiatry, 215(2), 494-501. doi:10.1192/bjp.2018.302
  12. 31. Bartova, L., Dold, M., Kautzky, A., Fabbri, C., Spies, M., Serretti, A., Souery, D., Mendlewicz, J., Zohar, J., Montgomery, S., Schosser, A., & Kasper, S. S. (2019). Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice. The world journal of biological psychiatry, 20(6), 427-448. doi:10.1080/15622975.2019.1635270
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>